Springtime Storylines: Will B.J. Upton finally break out for the Rays?

Leave a comment

Between now and Opening Day, HBT will take a look at each of the 30
teams, asking the key questions, the not-so-key questions, and generally
breaking down their chances for the 2010 season.  I started with the Yankees, so I bet you thought I’d go Red Sox next, eh kitty cat? But I pulled the string like Johan Santana, didn’t I? Is your mind blown?!

The big question: Will B.J. Upton finally break out?

Just because I don’t have an answer to a question doesn’t mean it’s not worthy of being asked. And truth is, I have no idea if Upton is going to do more in 2010 than he did in what was a very disappointing 2009. Disappointing in part because his 2007 regular season and 2008 postseason were so great. Disappointing because he’s obviously got power, plate discipline, speed and the defensive skills to be a game-changer, yet last year he was utterly flaccid, with the biggest concern being the drastic falloff in his walk rate.

Upton was coming off labrum surgery entering last season and, by all accounts, he’s working his tail off this spring.  If that translates to something approaching his 2007 production the Rays are going to be scary as all get-out. If he puts up another .241/.313/.373, the Rays’ offense — while still impressive — will remain a step or two behind their big brothers in the AL East.

So what else is going on?

  • The acquisition of Rafael Soriano changes the complexion of the Rays’ bullpen.  Soriano split time with Mike Gonzalez as the Braves’ closer last year, but he’s better than a lot of guys other teams will trot out in the ninth this season. He has a lot of mileage on that arm, however — Bobby Cox has a thing for treating relievers with a history of arm trouble as so much Kleenex — but if he stays healthy he moves J.P. Howell, Grant Balfour, Dan Wheeler, Lance Cormier and Randy Choate down in the hierarchy, which improves things nicely;
  • Carl Crawford and Carlos Pena are likely in their last go-around as Rays.  It seems like a foregone conclusion that Crawford will leave via free agency after this season. If you’re the Rays you probably keep him and accept the picks whether you fall out of the race or not. Pena may be a different story. He’s not exactly a sterling free agent candidate — there are a lot of big name first basemen coming available soon — so he could very well accept arbitration if offered.  The Rays will obviously need him in a race, but if they disappoint this year, he could be dealt;
  • Joba and Phil get all the press, but there’s been a much less-publicized fifth starter race in Tampa Bay between Wade Davis and Andy Sonnanstine.  Davis got shelled the one day I saw him this spring, but most folks think that he has the edge. Ahead of them, you can expect James Sheilds and Matt Garza to be solid. Jeff Niemann and David Price have tremendous upside — with Niemann having realized more of his than Price has thus far — so how the Rays pitching fares probably depends a lot more on those two than anyone. If any of them falter, Jeremy Hellickson is waiting in the wings.
  • Wild cards:  Even if Carl Crawford hangs around, it’s not beyond credulity to think that heir apparent Desmond Jennings will see some time in the Rays’ outfield, most likely in right if Matt Joyce and Gabe Kapler can’t cut it.  Late pickup Hank Blalock has turned heads during his brief time in camp and could make the roster, pushing Pat Burrell into a platoon situation at DH and shuffling the Rays bench.  Don Zimmer is still coaching, and it’s been a while since we’ve seen closeups of his ugly mug in the playoffs and, quite frankly, I miss it.

So how are they gonna do?

There are a lot of guys on this team that can be expected to take steps forward this year and none that I can think of who should be expected to take a major step back. Maybe Zobrist. They have a lot of premium talent that is just about major league-ready. Assuming nothing but the positive is a good way to find disappointment in this ugly world, but I think that the Rays are going to be a significantly improved team in 2010, and they were already pretty darn good.

Prediction: Second place in the AL East and Wild Card winners.  That’s right, ahead of the Red Sox in what I think will be the closest race in baseball this year.  Sox fans may now commence their whining. But save some, because I’m doing the Sox preview next and you don’t want to tire yourselves out.

Dee Gordon’s suspension is likely to lead to a call for harsher PED penalties

Miami Marlins' Dee Gordon celebrates after hitting a double against the Detroit Tigers in the ninth inning of a baseball game Tuesday, April 5, 2016, in Miami. Derek Dietrich scored on the double. The Tigers won 8-7. (AP Photo/Alan Diaz)
Associated Press
19 Comments

Objectively speaking there is no difference between Dee Gordon’s suspension for PEDs and anyone else’s. Abraham Almonte, for example. Or Cameron Maybin. Or David Rollins. All were guys who got their 80 games, served their time, came back and whose cases didn’t raise too much of a fuss. But Gordon’s suspension will almost certainly be talked about longer and more loudly and will likely lead to calls for harsher penalties and changes to the PED suspension rules.

Part of it is simply fame. He’s a pretty big name as far as these things go. The biggest since the Biogenesis guys a couple of years ago. He won the batting title last year. He’s the son of a famous major leaguer. There is a direct correlation between the volume and intensity of the narratives applied to one’s story and the fame of the subject of the story. For that reason alone Gordon’s story will last longer and loom larger.

Another reason — a bigger reason, I think — is timing. Gordon was seen by many to have had a breakout season in 2015 and, when it was over, he was rewarded for it with a nice five-year $50 million deal. The narrative will arise by, oh, 9AM today, that the suspension was “worth it” for Gordon and that he cashed in because of it, rendering his suspension a mere slap on the wrist. This is especially true given that his deal is severely backloaded. He’ll lose less than $2 million in salary in 2016 while collecting the other $48 million-plus. Totally worth it!

I understand why people will say that, but such a stance has some serious flaws. Among them:

  • It assumes that we or anyone else knows when Gordon began to take PEDs;
  • It assumes that we or anyone else knows how, in fact, Gordon’s performance was actually enhanced;
  • It forgets that lots and lots of people were talking about how Gordon’s “breakout season” was actually 2014, not 2015, rendering that whole “he juiced and then got his money” argument fairly problematic.

Those points will likely be ignored as arguments in favor of harsher penalties grow louder. Ken Rosenthal reminds us this morning that some have called for some form of contract voiding or clawing back of more money than just the salary earned while on suspension. Those calls too will likely grow louder. There will also be calls for changes in the appeal process. Like this one, which came moments after Gordon’s suspension was announced:

When you have an actual union member angrily call for the repeal of a collectively-bargained protection in punishment situations, you’re sort of through the looking glass. Or past a tipping point. Or something. You’re certainly in a world where the usual dynamics between employer and employee are not operative and, as a result, changes are inevitable. As we noted recently, players today are perhaps more adamantly anti-PED than the owners and the league are. They’re competitors reacting to cheating by their competition. The fuel for stronger penalties is likely to come more from them than anyone.

The union and the league will be negotiating a new Collective Bargaining Agreement this year. Performance enhancing drugs and their penalties will be a part of that. Expect harsher penalties and possibly different sorts of rules altogether. Expect Dee Gordon to be the poster child for these changes, even if his case is no different in form than that of Abraham Almonte, Cameron Maybin, or David Rollins. Expect emotion, rather than logic, to lead the coming debate.

And That Happened: Thursdays scores and highlights

Atlanta Braves relief pitcher Arodys Vizcaino, right, is congratulated by catcher Tyler Flowers after earning a save during a baseball game against the Boston Red Sox at Fenway Park in Boston, Thursday, April 28, 2016. The Braves defeated the Red Sox 5-3. (AP Photo/Charles Krupa)
5 Comments

Gonna mail this one in this morning. Partially because of the light slate of games yesterday, partially because of a late night for me but mostly because of the Dee Gordon news which has me thinking of a lot of other things I want to write about this AM.

It’s worth noting that the Braves won a game. It comes just ahead of a series at Wrigley against the Cubs, so the winning streak will likely last a single day, but the 2016 Braves have to take what they can get.

The Marlins had a notable night outside the Gordon news too, finishing off a sweep of the Dodgers, which had to make Don Mattingly happy. For what it’s worth, Gordon singled in a run and then came around to score in the seventh. His RBI tied it and the run he scored ended up being the one necessary for the Marlins’ margin of victory. That means nothing, but you know some jackwagons are gonna make a big deal out of that and I figured I’d get ahead of the jackwagons and note that, yes, Gordon and the Marlins knew what was coming before it was announced because that’s how the appeals process works, but no, it makes no difference, because that’s how the appeals process works.

Anyway: Here are the rest of the scores:

Tigers 7, Athletics 3
Cubs 7, Brewers 2
Phillies 3, Nationals 0
Orioles 10, White Sox 2
Braves 5, Red Sox 3
Diamondbacks 3, Cardinals 0
Marlins 5, Dodgers 3
Pirates vs. Rockies — POSTPONED
: In the early morning rain with a dollar in my hand. And an aching in my heart, and my pockets full of sand. I’m a long way from home, and I miss my loved one so. In the early morning rain with no place to go.

Marlins 2B Dee Gordon suspended 80 games for PEDs

deegordon
Getty Images
40 Comments

LOS ANGELES — Dee Gordon has been suspended 80 games by Major League Baseball after the Miami Marlins second baseman tested positive for a performance-enhancing drug.

Gordon tested positive for exogenous Testosterone and Clostebol, MLB said in a release after the Marlins’ 5-3 victory over the Los Angeles Dodgers on Thursday night.

The fleet-footed Gordon won the National League batting title by hitting .333 last season and signed a $50 million, 5-year deal with Miami in January. He’s made two All-Star teams in his six seasons and won the Gold Glove and Silver Slugger awards at second base last year.

Gordon, the son of former major league pitcher Tom Gordon, had a key hit in Miami’s win over the Dodgers on Thursday. He’s batting .266 with six stolen bases this season.

Dee Gordon is a very important part of our team, and we all love him and support him,” Marlins president David Samson said. “That said, I don’t like or condone what he did. He is an important member of this organization and will be for many years to come. It’s a huge, huge disappointment to the kids, to our fans, to his teammates and to everyone in our organization every single day.

“He will be back 80 games from now, and he will be welcomed back to this organization. But in the interim period, we expect him, and we are positive that he will do everything that’s necessary to make it up to his fans, to his teammates and to this organization.”

Devon Travis will start taking at-bats in extended spring training

Toronto Blue Jays second baseman Devon Travis hits a RBI double to center field against the Tampa Bay Rays during third inning of a baseball game, Wednesday, April 15, 2015 in Toronto. (Nathan Denette/The Canadian Press via AP)  MANDATORY CREDIT
Nathan Denette/The Canadian Press via AP
4 Comments

Blue Jays second baseman Devon Travis underwent left shoulder surgery last September. MLB.com’s Gregor Chisholm caught up with Jays head athletic trainer George Poulis for updates on several injured players, including Travis. Here’s what Poulis had to say about Travis:

“He’s going to get some live at-bats with the extended team down in Florida on Friday. Big step for him, he’s very excited, he’s doing great, and we’re very optimistic, but no timeline right now on his return. We’re just going day by day, step by step.

“When you have something like that, it continues to heal even when you’re playing. We’re just trying to acclimate him and condition him to withstand all of the stress that he’s going to put on his shoulder … He won’t play in the field right now. We’ll mix that in, as well, but right now he’s just going to get some at-bats.”

The key phrase, of course, is “no timetable”. The second baseman’s rehab has gone slower than expected. Getting into some extended spring training games, though, signals progress.

Travis, 25, broke out last season, hitting .304/.361/.498 with eight home runs and 35 RBI in 239 plate appearances last season. The Jays have had Ryan Goins and Darwin Barney handle second base duties this year, but their aggregate .560 OPS is the worst mark in the American League.